20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Exploring the Enzymatic Activity of Heparinase I: Applications in Inflammation Research

Inflammation is a complex biological response critical for host defense but also implicated in the pathogenesis of numerous diseases. Understanding the molecular mechanisms that regulate inflammatory processes is a key focus in biomedical research, and enzymes that modify the extracellular matrix (ECM) often play a pivotal role. Heparanase I (CAS 9025-39-2) is one such enzyme, actively studied for its involvement in inflammatory pathways.

Heparanase I is known for its endoglycosidase activity, specifically its capacity to cleave heparan sulfate. Heparan sulfate, a component of heparan sulfate proteoglycans (HSPGs), is not merely a structural element of the ECM; it also acts as a crucial reservoir for various signaling molecules, including chemokines and growth factors that orchestrate immune responses. When Heparanase I cleaves heparan sulfate, it liberates these bound molecules, thereby modulating their availability and initiating or amplifying inflammatory cascades.

The enzyme's action can influence leukocyte recruitment, activation, and migration to sites of injury or infection. By affecting the bioavailability of chemokines, Heparanase I can directly impact the efficiency of immune cell trafficking, a fundamental aspect of both acute and chronic inflammatory conditions. Research into these mechanisms is vital for developing new therapeutic strategies to manage inflammatory diseases.

For scientists engaged in inflammation research, obtaining a reliable source of pure Heparanase I is essential. NINGBO INNO PHARMCHEM CO.,LTD. is a trusted manufacturer and supplier of this enzyme, offering a high-purity (99%) product. As a leading chemical supplier in China, we support researchers worldwide by providing the critical tools they need to advance their studies. Whether you are investigating the molecular underpinnings of autoimmune disorders, inflammatory bowel disease, or other conditions, our Heparinase I can be a valuable asset.

We encourage researchers looking to buy Heparinase I to consider our commitment to quality and consistency. Partner with NINGBO INNO PHARMCHEM CO.,LTD. for your research needs and contribute to the growing body of knowledge surrounding inflammation and its therapeutic targets.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: Procuring Heparinase I: A Strategic Decision for Pharma Manufacturers

Next: Heparanase I (CAS 9025-39-2): A Key Reagent for Studying ECM Remodeling

All Rights Reserved